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During protein synthesis, tRNA serves as the intermediary between cognate amino acids and their
corresponding RNA trinucleotide codons. Aminoacyl-tRNA is also a biosynthetic precursor and
amino acid donor for other macromolecules. AA-tRNAs allow transformations of acidic amino acids
into their amide-containing counterparts, and seryl-tRNASer donates serine for antibiotic synthesis.
Aminoacyl-tRNA is also used to cross-link peptidoglycan, to lysinylate the lipid bilayer, and to allow
proteolytic turnover via the N-end rule. These alternative functions may signal the use of RNA in
early evolution as both a biological scaffold and a catalyst to achieve a wide variety of chemical
transformations.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Transfer RNA (tRNA) enjoys the distinction of being discovered
as a biochemical entity (technically as sRNA) at virtually the same
time as its existence was predicted as an essential component in
protein synthesis. While tRNA would later receive attention as
the ﬁrst nucleic acid molecule to have its atomic structure deter-
mined by X-ray crystallography [1], thereby conﬁrming many of
the Watson and Crick base pairing postulates, Crick’s ‘‘adaptor
hypothesis” [2] remains a singular scientiﬁc achievement, because
it originated almost entirely from theoretical considerations asso-
ciated with the genetic coding problem. In the adaptor hypothesis,
Crick made the bold conceptual leap that no obvious physical and
chemical basis exists for associating particular combinations of the
four ribonucleotides with each of the 20 amino acids, so hydrogen
bonding and base pairing would have to remain the chemical basis
by which genetic information would ultimately be expressed.
Accordingly, a set of adaptors was proposed corresponding to the
20 canonical standard amino acids, each possessing a distinct
end to accommodate the cognate amino acid, and a second end
to interact with the templating RNA. These, in turn, would dictate
the existence of a set of aminoacylating enzymes, each one speciﬁc
for one of the 20 amino acids and their cognate adaptors. In con-
junction with a non-overlapping three base degenerate code, thischemical Societies. Published by E
Biochemistry, University of
enue, Burlington, VT 05405,
C.S. Francklyn).model provided a remarkably elegant and essentially correct reso-
lution to the coding problem.
Despite the durability of the adaptor hypothesis as a workable
answer to the coding problem, its principal assumptions were soon
challenged by new observations in the literature. Crick never enter-
tained the possibility that cells might be able to survive with less
than a full set of adaptor-charging enzymes, and yet still produce
proteins with all 20 amino acids. Similarly, the possibility that tRNA
adaptorsmight have roles outside of protein synthesiswas not envi-
sioned. By the late 1960s, however,Wilcox andNirenbergwould re-
port that some bacterial species lack a GlnRS ortholog, with Gln-
tRNAGln being produced by a transamidation reaction [3]. Unantici-
pated roles for tRNA also emerged in the synthesis of the peptide
crosslinker of peptidoglycan [4] and in lipid modiﬁcation [5], repre-
senting some of the ﬁrst forays of tRNA outside of protein synthesis.
Yet while these observations were being reported, theoretical
work during this period addressed the importance of self-replicat-
ing nucleic acids in the origin of life, and the potential signiﬁcance
of small molecules linked to RNA [6]. The possibility that RNA
might be able to catalyze aminoacylation was also noted (and val-
idated much later [7]). Others would later propose that modern
day enzymatic co-factors, particularly nicotinamide and ﬂavin co-
factors, are vestiges of the RNA world [8]. Support for the impor-
tance of pre-biotic chemistries involving RNA-based catalysis
would later come with the discovery that RNase P [9] and the ribo-
some [10,11] both have RNA-based catalytic engines, and with the
development of in vitro selection protocols that allowed catalytic
RNAs to be isolated from large complexity nucleic acid poolslsevier B.V. All rights reserved.
C.S. Francklyn, A. Minajigi / FEBS Letters 584 (2010) 366–375 367[12]. With the current explosion of new regulatory roles for small
RNAs [13], it is perhaps a timely occasion to consider some of the
functions of transfer RNA that are distinct from its canonical role in
protein synthesis. Here, we review the ‘‘non-protein synthesis”
roles of tRNA, particularly those in which it serves as a biosynthetic
scaffold for other biochemical functions (Fig. 1). Interestingly, a
number of these secondary functions are concerned with the plas-
ma membrane and the cell wall, structures that separate the con-
tents of the cell from its external environment. In other functions,
the aminoacylated tRNA serves as a substrate for further biosyn-
thetic transformations, generating ﬁnal compounds whose func-
tions are outside the realm of protein synthesis.
2. tRNA as an active participant in reaction chemistry
The concept of tRNA as an active chemical scaffold implies that
speciﬁc chemical reactions involving the aminoacyl moiety are
facilitated as a direct consequence of the presence of the tRNA. Re-
cent work on a number of reactions, including peptidyl transfer,
aminoacyl transfer, and deacylation, underscores a potential cata-
lytic role for tRNA. As representative examples, we focus here on
reactions that are localized to one of the two vicinal hydroxyls of
nucleotide A76, which constitutes the 30 terminus [14]. Each hy-
droxyl group is able to engage in H-bonds as either a donor or
acceptor, making these groups particularly valuable for bridging
interactions between the tRNA, the enzyme, and the solvent. Rela-
tive to a free hydroxyl group, the pKa’s of these vicinal groups are
depressed by at least three units (12.5 vs. 16 units for ethanol),
implying a higher degree of reactivity than for a single hydroxyl
group.Fig. 1. Secondary roles of tRNA in cellular metabolism. The canonical roles of tRNA in pr
‘‘Ribosomal Protein Synthesis”, while other functions discussed in this review are arrange
particular process, the tRNA molecule shown in the circle should be considered as eith
discussed in the text.A particularly signiﬁcant example of the direct participation of
the vicinal hydroxyls in reaction chemistry is found in the peptidyl
transferase reaction [15]. One component of the ribosome’s
enhancement of the rate of peptidyl transfer is the deprotonation
of the a-NH3 group on the A-site tRNA, which serves as the nucle-
ophile. The 30OH leaving group on the P-site tRNA must also be
protonated. There is an absence of protein-based catalytic groups
in the ribosomal 50S subunit structure where the peptidyl trans-
ferase center is located, motivating the search for RNA-based func-
tional groups able to contribute to catalysis [11]. While early
attention initially focused on A2451 of the 23S large subunit RNA
[11,16], experiments featuring mutant ribosomes subsequently
showed that this nucleotide does not make an essential contribu-
tion to catalysis [17,18]. Analysis of ribosome crystal structures
indicates that one of the only ionizable groups in the neighborhood
of the NH2 nucleophile is the 20OH of the P-site tRNA, highlighting
it as a possible general base [19]. Support for this model was pro-
vided by tRNA substitution experiments, which showed that there
is an 106-fold decrease in the rate of peptidyl transfer when the
20OH is replaced by a deoxy or ﬂuoro [20]. While the catalytic
power of the ribosome likely has a number of different origins,
including a signiﬁcant entropic component originating from ﬁxing
the geometry of the reactants, as well as excluding solvent water
[21,22], a proton shuttle mechanism (Fig. 2A) involving the P-site
20OH is arguably an important catalytic element. In such a mecha-
nism, the concerted nature of the proton transfer means that the
20OH need not assume a full charge during the reaction, arguing
that a major pKa perturbation is not required [14].
Recent studies have provided evidence that similar mechanisms
may be involved in the aminoacyl transfer and deacylation reac-otein synthesis are represented by ‘‘Chemistry of Aminoacylation and Editing” and
d in a circular fashion around a central tRNA molecule. Depending upon its role in a
er free tRNA (as shown) or an aminoacyl-tRNA. The details of these processes are
Fig. 2. Role of tRNA in facilitating key steps in protein synthesis. (A) Substrate-assisted catalysis of peptide bond formation in the ribosome, adapted fromWeinger et al. [20].
The a-amino group of the A-site tRNA (blue) serves as the nucleophile in the attack on the carbonyl carbon of the P-site tRNA (magenta). The speciﬁc function of the 20OH as a
general base in the reaction is still under investigation. (B) Substrate-assisted catalysis of aminoacyl transfer by threonyl-tRNA synthetase, adapted from Minajigi and
Francklyn [23]. The threonyl adenylate is depicted in blue, and the A76 group of incoming tRNAThr in magenta. (C) Proposed role for the adjacent hydroxyl of A76 in stabilizing
the geometry of the attacking water molecule in the deacylation of Thr-tRNAPhe by phenylalanyl-tRNA synthetase, adapted from Ling et al. [26]. The decreases in aminoacyl
transfer by threonyl synthetase and post transfer editing by phenylalanyl-tRNA synthetase associated with removal of the adjacent hydroxyl are of the same order (750- vs.
300-fold, respectively), but several orders magnitude less than the effect of loss of the adjacent hydroxyl on peptidyltransferase (106).
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enzymes catalyze a two step reaction in which amino acid and
ATP are ﬁrst condensed to form an enzyme linked adenylate, fol-
lowed by a subsequent step in which the amino acid is transferred
to the 30 end of the cognate tRNA. In ThrRS, a systematic study of
the conserved and likely catalytic residues in the active site
showed that only one (His309) is likely to be directly involved in
aminoacyl transfer [23]. Notably, His309 is hydrogen bonded to
the 20OH of tRNAThr [24]. Substitution studies on ATP and tRNA
substrates showed that replacement of the non-bridging oxygen
of the adenylate with sulfur had only minimal effect on the rate
of transfer, whereas substitutions of the 20OH with deoxy or ﬂuoro
signiﬁcantly decreased (100- to 700-fold) the rate of aminoacyl
transfer [23]. Notably, there was a synergistic effect of combining
the 20OH substitution with a His309A substitution. Accordingly, a
‘‘proton transfer” model (Fig. 2B) for the activation of tRNAThr
was proposed where His309 assists in the deprotonation of the
20OH, which in turn assists in the activation of the 30OH [23]. An
analogous proton shuttle has been proposed for liver alcohol dehy-
drogenase, where the substrate alcoholic protein is transferred ﬁrst
to a conserved serine, then to one of the vicinal hydroxyl groups of
the co-factor NADH ribose, and then ﬁnally to a conserved histidine
[25]. These observations draw an explicit functional parallel for the
ﬁrst time between a tRNA and a nicotinamide-based co-factor, sup-
porting the White hypothesis [8] that contemporary co-factors are
remnants of early RNA-based metabolism.
A catalytic role for the vicinal hydroxyl of the A76 of tRNAPhe in
the ARS-catalyzed deacylation of mis-charged-tRNA similar to that
of ThrRS was proposed in the PheRS system [26]. A survey of the
PheRS editing active site by scanning mutagenesis showed that
none of the active side chains contributes signiﬁcantly to deacyla-
tion. Loss of the 30OH, however, dramatically slowed deacylation,
leading to the model that the vicinal hydroxyl assists in catalysis
by helping to activate a catalytic water molecule for attack on
the aminoacyl ester (Fig. 2C). The ablation of the adjacent A76 hy-
droxyl in those tRNAs that participate in editing in other systems is
also been accompanied by signiﬁcant losses in activity [27,28].
These results suggest that substrate-assisted catalysis, particularly
that involving adjacent hydroxyl groups of A76, may be a general
feature of diverse tRNA reactions. One hallmark of such reactions
may be the relative insensitivity of the reaction to amino acids sub-
stitutions in active site residues adjacent to the scissile bond.3. AA-tRNA as a precursor in synthesis of other tRNAs
In many bacterial genera and in all Archaea, several canonical
ARS are missing. The most frequently missing ARS is GlnRS, but
asparaginyl- (AsnRS) and, in several Archaeal genera, cysteinyl-
tRNA synthetase (CysRS) can also be absent [29]. To compensate
for the missing ARSs, these species employ indirect pathways in
which one amino acid serves as precursor, i.e. glutamate is con-
verted to glutamine, aspartate is converted to asparagine, and ser-
ine is converted to cysteine [29]. In all of these pathways, an initial
AA-tRNAAA intermediate is produced by a mischarging reaction
that joins the precursor amino acid to the cognate tRNA with the
appropriate anticodon for the eventual product. The intermediate
is enzymatically converted into the ﬁnal amino acid, thereby creat-
ing a cognate aminoacyl-tRNA that can participate in translation. In
addition to the three canonical amino acids listed above, seleno-
cysteine is also incorporated into proteins via an indirect pathway
[30]. All indirect pathways share several common features, includ-
ing a ‘‘non-discriminating” ARS that is able to aminoacylate the
tRNA associated with the indirect pathway as well as its standard
cognate tRNA; chemical activation of one or more small molecule
substrates; and the coupling of aminoacyl-tRNA binding to other
enzymatic activities distal to the immediate site of tRNA binding,
such as the production of ammonia by the glutaminase site in
the amidotransferases (described below).
Among the indirect pathways, the best-characterized are those
associated with formation of Gln-tRNAGln and Asn-tRNAAsn. Two
different families of amidotransferases are responsible for catalyz-
ing the reaction, the heterotrimeric GatCAB [31] and heterodimeric
GatDE [32]. In the bacteria, GatCAB can function as both a gluta-
mine amidotransferase (Gln-AdT) and an asparagine amidotrans-
ferase (Asn-AdT) [29]. In Archaea, GatDE is always a Gln-AdT and
GatCAB is an Asp-AdT. Following a heterologous aminoacylation
by a non-discriminating ARS, the basic amidotransferase reaction
is identical in both families [29]. In the ﬁrst step, the terminal car-
boxylate of the aminoacyl-tRNA (Asp-tRNAAsn or Glu-tRNAGln) is
phosphorylated, activating it for the subsequent transfer step.
Next, a glutaminase activity cleaves glutamine to liberate ammo-
nia, which is then transported to the active site where the amino-
acyl moiety is bound. (This activity can be complemented by free
NHþ3 in the reaction.) Finally, the amidotransferase amidates the
activated intermediate to form Gln-tRNAGln or Asn-tRNAAsn. Thus,
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localized to GatB or GatE, to a glutaminase activity, localized to
GatA or GatD.
To ensure a 1:1 stoichiometry between the equivalents of
ammonia generated and equivalents of aminoacylated tRNA
formed, the activities of the two catalytic sites must be tightly
coordinated. The X-ray structures of GatCAB [33] and GatDE [34]
suggest the existence of ‘‘tunnels” in both complexes that connect
the glutaminase and amidase active sites. In the dimeric histidyl-
and threonyl-tRNA synthetases, there is evidence that the presence
of tRNA provides allosteric coupling between the amino acid acti-
vation reactions carried out in both active site of the dimer, equal-
izing the rates of reactions which are unequal in the absence of
tRNA [35,36]. In both Gln-AdT and Asn-AdT, one hypothesis is that
the presence of tRNA similarly serves to couple the activity of the
two active sites, thereby preventing the wasteful liberation of free
ammonia from glutamine under conditions where Glu-tRNAGln and
Asp-tRNAAsn are not available to receive it. This remains to be
tested experimentally. Similarly, all indirect pathways generate a
mis-charged aminoacyl-tRNA species that would be detrimental
to growth, were it allowed to enter protein synthesis. This is likely
prevented in two ways. First, elongation factors (and the ribo-
some’s A-site) have been shown to discriminate against mis-
charged tRNA at the level of binding [37,38]. Secondly, the forma-
tion of a direct complex between the non-discriminating ARS and a
Gln-AdT or Asn-AdT may provide an opportunity for ‘‘substrate
channeling” between the synthetase and the transamidase, such
that the aminoacyl-tRNA intermediate formed by the ARS is pre-
vented from entering the general pool of charged tRNAs for protein
synthesis. Evidence for a ‘‘transamidosome” is still in the formative
stages [39,40]. The transamidosome protects the aspartyl-tRNAAsn
from hydrolysis, by some 1.4- to 2-fold relative to free tRNA. Disso-
ciation of the ﬁnal tRNA appears to be the rate-limiting step. One
complication associated with complex formation is that GatCAB
is required to associate with both class I and class II ARS: tRNA
complexes, which recognize different faces of their cognate tRNAs.
(GatDE is only obliged to form a complex with Class I GluRS, so
there is not this issue.)
The entrance of both selenocysteine and cysteine into protein
synthesis requires indirect pathways for aminoacyl-tRNA forma-
tion, and these share several interesting similarities [29]. A critical
difference between the two is that cysteine is coded directly in the
genetic code, while selenocysteine employs a complex mechanism
involving recoding of the UGA stop codon. (Details of this latter
process are outside the scope of this review.) Selenocysteine is
formed only by the indirect pathway, whereas cysteine can be
formed through both a direct route, requiring the canonical
cysteinyl-tRNA synthetase (CysRS), or an indirect route, which
requires the transformation of phosphoseryl-tRNACys into Cys-
tRNACys [41]. The existence of the indirect pathway was ﬁrst
established in those methanogenic Archaea in which the canonical
CysRS is absent [42]. Subsequently, additional genera were identi-
ﬁed in which the direct pathway is dispensable [43].
The indirect pathway for cysteinyl-tRNACys formation consists
of a series of linked reactions [41]. First, tRNACys is aminoacylated
with phosphoserine by a dedicated ARS (SepRS) to form phospho-
serine-tRNACys. This intermediate is subsequently converted to
Cys-tRNACys by the action of SepCysS, a pyroxidal phosphate
dependent enzyme [41]. The form in which sulfur is donated is
not yet known, but one possible scenario, suggested by the rela-
tionship between SepCysS and the cysteine desulfurases CsdB, NifS,
and IscS, is that a persulﬁde intermediate is involved [44,45]. As
described above for the indirect glutamine and asparaginyl-tRNA
pathways, the entrance of phosphoseryl-tRNACys into protein syn-
thesis must be blocked. Poor afﬁnity of EF-Tu is clearly one factor
[46], and there is some evidence that supports the existence of acomplex between SepRS and SepCysS [47]. SepRS is a tetramer,
while SepCysS is a dimer [45,48,49]. A signiﬁcant question that re-
mains is how they interact, and the mechanism by which the ami-
noacyl-tRNA is handed off from SepRS to SepCysS [45].
The mechanisms for the formation of selenocysteine-tRNASec
differ between the prokaryotes and eukaryotes. In bacteria, tRNASec
is aminoacylated by SerRS, which essentially behaves like a ‘‘non-
discriminating” ARS in this context, able to aminoacylate both
tRNASer and tRNASec [30]. Selenium is introduced into the system
in the form of selenophosphate, which is synthesized by SelD.
The key enzyme in the pathway, selenocysteine synthase, employs
Ser-tRNASec and selenophosphate as substrates, producing the Sec-
tRNASec that functions directly in protein synthesis, albeit by a spe-
cial recoding pathway that involves a dedicated elongation factor
(SelB) and a special structural context around the UGA codon
where selenocysteine is incorporated.
The archaeal/eukaryotic pathway for incorporation of seleno-
cysteine resembles the indirect Cys-pathway with respect to the
phosphoseryl-tRNA intermediate. A notable parallel between the
indirect cysteine and selenocysteine pathways is that the key en-
zymes that transform the aminoacyl-tRNA intermediates are PLP-
dependent enzymes [50,51]. In the eukaryotic pathway, tRNASec
is aminoacylated with serine, and then phosphorylated by the O-
phosphoseryl-tRNA kinase (PSTK) [52]. The resulting Sep-tRNASec
is converted to Sec-tRNASec by the action of SepSecS, which uses
selenophosphate [51,53]. Crystal structures of SepSecS have been
solved from Methanococcus maripaludis [54], mouse [55], and hu-
man [56]. All three orthologs are homotetrameric, with their active
sites localized at the dimer interface. In the proposed mechanisms
for both reactions, the Schiff base between the PLP and conserved
lysine is attacked by the a-NH3 group of the amino acid, forming an
aldimine. Upon loss of phosphate, this species is converted into an
aminoacryl-tRNA intermediate, which then undergoes attack by
either sulfur (in the indirect cysteine pathway) or selenophosphate
(in the selenocysteine pathway). While the cysteine and selenocys-
teine mechanisms share similarities with respect to the structure
of the intermediates, sulfur and selenium are added across the
double bond of the aminoacryl-tRNA intermediate by different
chemistries. Sulfur addition may occur via a persulfated SepCysS
intermediate, while selenium addition in SepSecS may simply re-
quire selenophosphate. In contrast to the aminoacylation and pep-
tidyl transferase reactions, tRNA serves as an essentially passive
scaffold in both reactions, and a role for the adjacent 20OH has
not been invoked in either case.
A general principle of indirect pathways for aminoacyl-tRNA
synthesis is that the interactions among the enzymatic compo-
nents of the pathway serve to limit the incidental transfer of ami-
noacyl-tRNA intermediates into protein synthesis before the
required chemical transformation is completed. One potentially
general strategy is the formation of biologically/physiologically
stable complexes between the non-discriminating ARS and the
next enzyme in the transformation pathway. In the case of the
AspRS/AdT transamidosome, the tRNA plays an essential role in
bringing the components together [39]. After formation of the ﬁnal
cognate product, the AspRS/AdT transamidosome has to dissociate
in order for the product to be released. Provided that such com-
plexes actually form, the scaffolding model requires that the CCA
end translocate from the aminoacylation active site to the amido-
transferase active site. This translocation event may be subject to
coordination with the rate of another chemical process (e.g. ammo-
nia formation). Signiﬁcantly, modeling of the AspRS/AdT transam-
idosome indicates that the appropriate geometry for these relevant
partners is available. Translocation is thus reminiscent of amino
acid editing in the class I and class II ARSs, which is generally
dependent on structurally distinct aminoacylation and editing
sites.
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interpeptide bridge synthesis of bacterial peptidoglycan
Peptidoglycan is a macromolecular, multilayer complex struc-
ture that maintains bacterial cell shape and prevents damage from
internal osmotic pressure. The peptidoglycan polymer is composed
of alternating N-acetyl glucosamine (NAG) and N-acetylmuramic
acid (NAM) units, joined together by b-1? 4 linkage. A pentapep-
tide stem extends from the carboxyl group of NAM, and the stems
of different chains are linked together via a peptide bridge. In
Staphylococcus aureus, the bridge consists of ﬁve glycines, and is
initiated at the e-amino group of Lys3 on one peptide stem and ter-
minates at D-Ala4 on the other peptide stem. The composition and
sequence of the ‘‘stem” and ‘‘bridge” peptides varies between dif-
ferent bacterial species. Peptidoglycan synthesis involves a cyto-
plasmic as well as membrane phase, consisting of multiple sets
of distinct enzymes, substrates, metal ions and coenzymes.
In S. aureus, the synthesis of the peptide stem involves the
sequential action of the Mur family enzymes. These enzymes use
free amino acids as substrates, linking them sequentially at each
of the successive carboxyl moieties of NAM [57]. By contrast, AA-
tRNAs are used as amino acid donors for synthesis of the peptide
interbridge. The involvement of an RNA component was proposed
nearly ﬁve decades ago, when the RNase-sensitive nature of pepti-
doglycan synthesis was ﬁrst observed [58]. Peptide interbridge
synthesis is insensitive to antibiotics that typically block protein
synthesis, suggesting that bridge synthesis is ribosome-indepen-
dent [4]. The use of charged tRNAs in cell wall synthesis was the
ﬁrst non-canonical function attributed to AA-tRNAs synthesized
by ARSs. The ﬁrst AA-tRNA to be identiﬁed was Gly-tRNA, which
could be demonstrated to participate in the addition of the ﬁrst
glycine in the bridge peptide [4]. This process was subsequently
shown to be dependent on glycyl-tRNA synthetase, tRNA and ATP
[59]. The generality of this approach and its extension to other AA-
tRNAs, including Thr-tRNA, Gly-tRNA and Ser-tRNA, was demon-
strated several years later [60,61]. Interestingly, at least one of
the glycine tRNAs in S. aureus is restricted to peptidolglycan
cross-bridge synthesis, showing no activity in canonical protein
synthesis [62]. The molecular basis of this restriction has not been
resolved, and poses an interesting problem with respect to com-
partmentalization of cellular components.
The sequential synthesis of the pentapeptide bridge is catalyzed
by the Fem XAB families of enzymes, which have been studied by a
combination of genetic, biochemical and structural approaches.
Fem is an abbreviation based on ‘‘factors essential for methicillin”
resistance, and includes FemX (now fmhB), Fem A, and Fem B. All
enzymes in the class are non-ribosomal peptidyl transferases,
and are members of the GCN5-related N-acetyltransferase (GNAT)
superfamily [63]. FemX catalyzes the addition of the ﬁrst glycine at
the e-amino group of lysine, while Fem A adds the second and third
glycines. The sequential addition of the last two glycine residues is
catalyzed by Fem B [64], which adds these residues by a polarity
(C-terminal to N-terminal) that is opposite to that of ribosome-
mediated protein synthesis. Glycyl-tRNA is the source of glycine
for each of the ﬁve glycines [65]. The speciﬁcity and essential nat-
ure of these enzymes was initially suggested by genetic analysis,
which demonstrated that fem mutants showed reduced glycine
in their cell walls, reduced cell wall turnover, and greater sensitiv-
ity to antibiotics. Although Fem A and Fem B are 39% identical, Fem
B cannot substitute for Fem A [66]. Therefore, these enzymes show
position-dependent activity during pentapeptide bridge synthesis,
even when they are expressed in a heterologous system, and exhi-
bit a form of functional ‘‘cross-talk” [67].
The crystal structure of the FemX enzyme from Lactobacillus vir-
idescens (or Weisella viridescens) showed two long channels run-ning across the surface for the binding of the two substrates,
UDP-MurNAc-pentapeptide and AA-tRNA [68]. The conformation
of the former substrate is in a bent conformation, while the orien-
tation of the latter is currently unknown. Interestingly, structural
comparisons with the tRNA binding to seryl-tRNA synthetase re-
vealed that the helical arms of the FemX and FemA proteins con-
tain ﬂexible arms that can participate in tRNA binding [68,69].
FemX exhibits an ordered sequential mechanism where UDP-Mur-
NAc-pentapeptide binding leads that of Ala-tRNAAla, followed by
ordered product release with deacylated tRNAAla [70]. The speciﬁc-
ity of the Fem enzymes with respect to amino acid and tRNA sub-
strates has been studied in detail. FemXWv exhibits a preference for
Ala-tRNAAla over Ser-tRNASer or Gly-tRNAGly, but shows no require-
ment for the post-transcriptional modiﬁcations present in mature
tRNAAla and tRNASer molecules. With respect to different tRNA
identity elements, C71, and C72 are essential for FemXWv but the
G3-U70 pair that serves as a crucial identity element for alanyl-
tRNA synthetase is not required [71]. Non-cognate tRNAs are ex-
cluded on the basis of both the aminoacyl moiety and the sequence
of the tRNA. L-Alanine is preferred 110-fold over D-alanine, sug-
gesting relatively weak speciﬁcity towards different stereoisomers.
The exclusion of serine is due to steric hindrance at the FemXWv ac-
tive site rather than nucleotide sequence of tRNASer. The exclusion
of glycyl-tRNAGly is mediated by the presence of the C2-G71 base
pair of tRNAGly, which acts as anti-determinant, rather than the
glycyl moiety [72].
The FemXAB enzymes all function as AA-tRNA dependent non-
ribosomal peptidyl transferases. The current model for the mecha-
nism of the transferase reaction catalyzed by these enzymes sug-
gests that, in contrast to ribosomal peptidyl transferase, all
principal catalytic roles are carried out by enzyme functional
groups rather than by those of tRNA [70]. This mechanism imposes
a requirement for a general base to de-protonate the a-NH3 group
of the lysine nucleophile, and a general acid to protonate the
tRNAAla leaving group. The pH rate proﬁle of the LvFemX enzyme
is bell-shaped, and suggests that groups with pKa’s 5.5 and 9.3
are important for catalysis. Structural information, as well as com-
parative sequence analysis, suggests that a conserved Asp is the
general base, while a conserved Tyr or Lys serves as general acid.
The Fem family enzymes are thus attractive targets for antimicro-
bial therapy, since these enzymes they possess a unique mecha-
nism and are universally absent from eukaryotes [73].
5. The role of AA-tRNA in the degradation pathway of proteins
Prokaryotic and eukaryotic cells possess highly speciﬁc systems
to ensure that protein turnover is carefully regulated. One major
route is the N-end rule, where the identity of the N-terminal resi-
due controls the half-life of the targeted protein in vivo [74]. In this
pathway, the amino terminus of the protein that undergoes turn-
over is extended at its N-terminus by a single residue. The resulting
modiﬁed protein is then processed by cellular proteolytic machin-
ery, which varies between species. The principal mechanism gov-
erning protein turnover in eukaryotic cells is polyubiquitination,
which involves conjugation of protein targets with ubiquitin, con-
verting them into substrates for the 26S proteosome. Bacterial cells
as a general rule do not regulate turnover through ubiquitination.
Rather, unstable proteins are readily bound to the AAA+ ClpA com-
plex, which delivers them to the ClpP peptidase with which ClpA is
directly associated [74]. Here, we focus on the tRNA-dependent
addition of amino acids that promote turnover. These are catalyzed
by the L/F and R-transferases, which are found in the prokaryotes
and eukaryotes, respectively. The involvement of tRNA in these
processes was originally suggested by the RNase sensitivity of
these reactions [74–76]. The following discussion focuses on the
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iﬁcation in eubacteria.
A monomeric enzyme of 234 residues, the L/F transferase cata-
lyzes the transfer of Leu/Phe to the NH2-terminal arginine or lysine
of the target protein [77]. It possesses two domains, an N-terminal
domain that is idiosyncratic to the family, and a C-terminal domain
that exhibits structural homology to the FemXAB family (Fig. 3)
[78]. The L/F transferase exhibits high speciﬁcity for the aminoacyl
moiety, but much less for the nucleic acid. Speciﬁcity for Leu and
Phe is nearly absolute, but Met and Trp can be tolerated at substan-
tially reduced activity. No activity is seen with Val, Ile, or Arg.
While there is very little speciﬁcity for the cognate tRNA, and oli-
goDNA/tRNA annealed hybrids are accepted as substrates, presen-
tation of the aminoacyl group via a single stranded RNA region is
required [79]. In contrast, the requirement for an arginine at the
NH2 terminus of the target peptide is absolute.
The ﬁrst complex of the Escherichia coli L/F transferase to pro-
vide signiﬁcant insights into substrate recognition was that with
puromycin, a chemical analog of the 30 end of aminoacylated tRNA
in which a p-methoxyl phenylalanine moiety is linked to an amino
6-N,N dimethyl adenosine group [78]. These groups are chemically
similar to the Phe and 30-adenosyl group of Phe-tRNAPhe. Puromy-
cin occupies a cleft in between the two domains of the L/F transfer-
ase, with the p-methoxy Phe binding to a hydrophobic pocket rich
in Phe and Met residues, and the dimethyl adenosine group being
recognized largely through p–p stacking with conserved Trp resi-
dues. Inspection of the binding pocket reveals that while Phe and
Leu are readily accommodated, an apparent steric clash exists with
amino acid substrates that are branched at the beta carbon. Thus,
the 30 terminus of the aminoacylated tRNA is recognized by the
combination of a largely hydrophobic pocket that interacts with
the amino acid, and more polar interactions with the 30 acceptor
end [79]. Notably, there are few obvious structural changes in
the enzyme that accompany binding. More detailed insight into
the reaction was provided by a complex between the L/F transfer-
ase, riboadenosyl-Phe (rA-Phe), and a short peptide (RYLGYL) de-
rived from casein which functions as an active acceptor [80]. The
former, a catalytically active substrate analog of a 30-aminoacyl ter-
minus, accurately mimics conformational features of the authentic
RNA substrate, including the ester bond and the C30 endo riboseFig. 3. A common fold for aminoacyl transfer in two different systems. (A) Structure
reported by Biarrotte-Sorin et al. [68]. The enzyme is depicted in ribbon form in magen
tRNA protein transferase from Escherichia coli, as reported by Watanabe et al. [80]. Theconﬁrmation, and binds essentially in the same pocket as puromy-
cin. When rA-Phe is soaked into a crystal of the L/F transferase with
the acceptor peptide, density for the adenosyl moiety is not ob-
served. However, new density for Phe appears at a location proxi-
mal to the N-terminal arginine. The terminal YL of the acceptor
peptide is not observed in the complex. Only N-terminal Phe and
Arg residues are speciﬁcally recognized, but rest of the acceptor
peptide recognition is sequence-independent.
Comparison of the rA-Phe and acceptor peptide complexes per-
mits a mechanism for the peptide bond formation reaction to be
proposed. Gln188, which is positioned to initially extract a proton
as a general base from the a-NHþ3 nucleophile then donate a proton
to the tRNA leaving group, appears to be critical. This mechanism is
analogous to a reverse acylation step catalyzed by chymotrypsin
[81]. Like the Fem XAB family, L/F transferase catalyzes a reaction
that is analogous to peptidyl transferase, but which relies on en-
zyme functional groups rather than the adjacent hydroxyl of A76
for proton transfer [80]. Interestingly, however, phenylalanylat-
ed-tRNAPhe with a 30 deoxy group is unable to transfer its amino-
acyl moiety to the donor peptide. Despite the presence of a
similar protein fold, FemWv and L/F transferase are characterized
by many functional differences, particularly with regard to poten-
tial catalytic residues. L/F enzyme has speciﬁcity for hydrophobic
amino acids, and does not require the acceptor stem [72].
6. Modiﬁcation of bacterial membrane lipids by aminoacyl-
tRNAs
Aminoacyl-phosphatidyl glycerol synthases (aa-PGs) attach dif-
ferent amino acids to the polar heads of phosphatidylglycerol
(PGs), effectively neutralizing the negative charge of the mem-
brane [82]. This mechanism decreases membrane permeability
and confers resistance to antibacterial peptides (defensins), and
cationic antibiotics (aminoglycosides, etc.). The presence of RNase
inhibited the formation of AA-PGs, suggesting the mechanism is
RNA dependent. Through reconstitutions of the minimal system
in vitro, AA-tRNA has been conﬁrmed as the amino acid donor.
The aa-PGs that have been investigated in most detail are MprF
(multiple peptide resistance factor) 1 and MprF2, which are
responsible for the synthesis of Ala-PG and Lys-PG, respectively,of FemX from Weisella viridecens, in complex with UDP-MurNAc-pentapeptide, as
ta, with the ligand rendered in stick form. (B) Structure of the leucyl/phenylalanyl-
adenosine moiety of the rA-Phe substrate analog is rendered in stick form.
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distributions in different organisms, with MprF1 activity being
found in Pseudomonas aeruginosa [85] while MprF2 is found in S.
aureus [86]. In both cases, the amino acid donors are AA-tRNAs.
Heterologous expression of S. aureus MprF leads to synthesis of
Lys-PG in E. coli, which otherwise does not synthesize it. Based
on the ability of MprF1 to efﬁciently recognize tRNAAla, tRNAPro,
and a minihelixAla, the speciﬁcity of MprF1 arises from the direct
recognition of the aminoacyl moiety of Ala-tRNA. Similarly, the
tRNALys species from Borrelia burgdoferi and humans, which share
less than 50% sequence identity, are also well recognized by MprF2.
Variation in the discriminator base of tRNA did not affect the activ-
ity of these enzymes. Thus, the nucleotide sequence of tRNA, the
anticodon, and the shape of the tRNA may not be required for
the activity of MprF proteins [84]. The activity of MprF raises the
issue of how AA-tRNAs are partitioned between their canonical
function of protein synthesis, and lipid modiﬁcation and cell
wall/cross-linking functions. A determination of the Kd’s of Lys-
tRNA for EF-Tu and MprF suggests that the two proteins have sim-
ilar afﬁnities for tRNA under physiological conditions [84]. An
interesting hypothesis that has not been experimentally tested is
that the different MprF-like proteins sample different AA-tRNAs
under different environmental contexts.7. The role of aminoacyl-tRNA as an intermediate in antibiotic
synthesis
For most of the pathways described above that feature amino-
acyl-tRNA as a donor, the product either feeds directly into protein
synthesis (indirect pathways for aminoacyl synthesis), into the
synthesis of peptides by non-ribosomal means (peptidoglycan
cross-linking), or into modiﬁcations where the amino acid moiety
remains largely intact (lipid modiﬁcation). Pathways also exist
where the donated amino acid moiety undergoes transformation
into a compound signiﬁcantly different from the parent compound.
One such example is the synthesis in Streptomyces viridifaciens of
valanimycin (Val), an azoxy-based antibiotic that includes the skel-
etons of the amino acids valine and serine in its structure [87]. Pro-
duction of the antibiotic is dependent on a gene cluster composed
of some 14 different genes [88]. Three of the genes, VlmD, VlmH,
and VlmR participate in the conversion of valine into the interme-
diate isobutylhydroxylamine. The latter compound attacks Ser-
tRNASer in a reaction catalyzed by VlmA, forming the intermediate
O-(L-seryl)-isobutylhydroxylamine [89,90]. In a series of steps not
yet deduced, this intermediate is converted into the ﬁnal product
valinamycin [91]. Notably, the Ser-tRNASer used in this reaction is
produced by a dedicated seryl-tRNA synthetase, VlmL [89]. It is un-
clear why a special tRNA synthetase is needed, as the reaction does
not involve a special tRNASer isoacceptor. In view of the essential
role of VlmL, and its inability to be substituted by the canonical
SerRS, complex formation between VlmL and VlmA may be re-
quired in order for the VlmA-catalyzed reaction to proceed. Of
note, VlmA is weakly related to MprF (23% identical, 46% similar)
[91]. Both share a common sequence motif (the DUF470 element),
which likely contains the MprF active site. Thus, it is possible that
VlmA recapitulates the active site domain of MprF, and that the ly-
syl-phosphatidyl glycerol transferase activity shares some degree
of similarity with VlmA’s activity, which transfers L-serine to iso-
butylhydrolxylamine. Such a similarity would imply a common
evolutionary lineage.
It would be surprising if valanimycin were the only example of
a ‘‘natural product” derived from amino acids, and this is in fact not
the case. Cyclodipeptides have recently emerged as another class of
secondary metabolites derived from aminoacyl-tRNA. Examples of
these compounds include cyclo (L-Phe-L-Pro) and cyclo (L-Phe-trans-4-OH-L-Pro). A number apparently have antibacterial and
antifungal activity. Prior to the recent work, the synthesis of cyclic
dipeptides was thought to occur exclusively by the action of non-
ribosomal peptide synthetases (NRPSs). These enzymes are modu-
lar in nature, and a separate adenylation domain selects the cog-
nate amino acid and joins it to ATP. Aminoacyl-tRNAs are not
part of this process. In a recently discovered pathway, synthesis
of the dipeptide albonoursin (precursor = cycle L-Phe-L-leu) was
reported to be catalyzed by AlbC, a 239-residue protein that bears
no sequence similarity to other proteins whose structure is known
[92]. Notably, AlbC was shown to require amino acid in the form of
aminoacyl-tRNA in order to catalyze albonoursin synthesis.
These initial studies featured the addition of exogenous tRNAs
to AlbC-containing extracts; the involvement of tRNA was later
conﬁrmed by a direct assay in which AlbC was incubated with
puriﬁed [14C]-labeled AA-tRNAs. Bioinformatics searches indicated
that potential AlbC orthologs exist in other bacteria genera includ-
ing the Firmicutes (Bacillus, Staphylococcus) Actinobacteria (Coryne-
bacterium, Mycobacterium) and c-Proteobacteria. The degree of
sequence conservation, however, is relatively low, with 19–27%
identity and 37–45% similarity. AlbC orthologs can be identiﬁed
by the consensus sequences Hx(lVI][LVI]G[LVI]S and Y[LVI]xxExP.
Notably, these are not found in any other proteins in the database.
When expressed in E. coli, these proteins also produced compounds
that could be identiﬁed as cyclic dipeptides, and the reactions em-
ployed AA-tRNA as substrate. For a number of these dipeptide syn-
thases, the dipeptide is an intermediate and not a ﬁnal product. For
example, the cFL peptide formed by AlbC is subsequently oxidized
by a cyclodipeptide oxidase to generate the authentic albonursin.
In other systems, the localization of cytochrome P450 enzymes
near the cyclodipeptide synthase (CDPS) enzymes suggests that re-
dox-mediated modiﬁcation of the cyclodipeptide intermediate
may a general feature of the modiﬁcation of these compounds.
As yet, the speciﬁcity determinants of AlbC and its homologs with
respect to tRNA are unknown. In view of their utilization of AA-
tRNAs as substrates, these biosynthetic pathways would be ex-
pected to compete with normal protein synthesis. Accordingly, it
is not unexpected that synthesis of their products would be maxi-
mal during log phase, which is seen for albonoursin in Streptomyces
noursei.8. The role of AA-tRNA in the synthesis of tetrapyrroles
The biosynthesis of hemes, chlorophylls, and bilins in plants, al-
gae, and some bacteria is regulated by the availability of the ﬁrst
metabolic intermediate, d-aminolevulinic acid (ALA). Synthesis of
ALA begins with the formation of Glu-tRNAGlu by glutamyl-tRNA
synthetase (GluRS), reduction of glutamate to glutamate-semialde-
hyde (GSA) by Glu-tRNA reductase (GluTR), and then ﬁnally the
transamidation of GSA to ALA by GSA aminomutase [93]. The con-
version of glutamate to ALA was decreased in the presence of ribo-
nuclease, which suggested the involvement of an RNA component
[94]; this was later conﬁrmed to be tRNAGlu [95]. The speciﬁcity for
tRNAGlu is absolute, as tRNAs speciﬁc for other amino acids are not
active in the reaction [96].
Subsequent work raised the possibility of separate tRNAGlu spe-
cies for translation and heme synthesis [97,98]. Two GluRSs are
present in Acidithiobacillus ferrooxidans, the ﬁrst a discriminating
GluRS-1 that glutamylates both tRNAGlu isoacceptors and tRNAGln,
and the second a non-discriminating GluRS that preferentially glu-
tamylates tRNAGln. GluRS-1 appears to be the enzyme most closely
associated with heme synthesis. When cells were grown under
high heme requirements (Fe2+), the level of GluRS-1 was increased.
However, under the conditions of excess heme synthesis (Fe2+/
ALA), GluRS-1 activity was drastically lowered without change in
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tions corresponded to the reduced GluRS-1 activity, suggesting
its regulation by heme. GluRS-1 was also found to be dispensable
for protein synthesis, suggesting that GluRS-2 is sufﬁcient to gen-
erate Glu-tRNA [93].
Substrate requirements and the mechanism of glutamate reduc-
tion by GluTR have also been examined. Notably, the activity of
GluTR on in vitro transcripts is comparable to its activity on tRNA
produced in vivo, suggesting that the post-transcriptional modiﬁ-
cations typically found in Glu-tRNA are not obligatory. GluTR also
possesses a conserved cysteine (Cys50) whose chemical modiﬁca-
tion or substitution via mutagenesis signiﬁcantly reduces GluTR
activity. It has been hypothesized that Cys50 attacks the a-carbon
of Glu-tRNA glutamate, forming a thioester intermediate (acyl-
enzyme), and releasing tRNAGlu. Reduction of the thioester
intermediate to GSA is subsequently accomplished using NADPH
as co-factor, facilitated by an active site histidine. Alternatively,
in the absence of NADPH, an esterase activity can release free glu-
tamate from the acyl-enzyme [99,100]. While sequence variations
in the acceptor arm and anticodon stem/loop of tRNAGlu apparently
have little effect on the activity of GluTR, variants harboring muta-
tions in the tertiary core (D-stem/loop, variable loop, and T-stem/
loop) exhibit signiﬁcant differences in their recognition by GluTR
[101]. Thus, Glu-tRNA presents a different set of identity determi-
nants for the two different enzymes, GluRS-1 and GluTR.9. Summary and perspectives
The list of reactions in a variety of cell types where AA-tRNA
serves as the amino acid donor for functions other than protein
synthesis continues to grow. As reviewed above, these include
reactions where the amino acid is used essentially in unmodiﬁed
form, as in the case of peptidoglycan cross-linking, lipid modiﬁca-
tion, and N-end rule conjugation. There are also examples where
the attached amino acid undergoes signiﬁcant chemical transfor-
mation, as seen in the indirect pathways for aminoacyl-tRNA for-
mation, for synthesis of antibiotics, cyclic dipeptides, and
tetrapyrrole synthesis. In these non-proteogenic pathways, the
data currently available suggest that the tRNA principally serves
as a molecular support, facilitating the transfer of the amino acid
from one active site (i.e. the aminoacylation active site) to the
other, where additional chemistry can occur. In contrast to the
aminoacylation and peptidyl transferase reaction, where the adja-
cent hydroxyl groups on A76 play an active role in chemistry, di-
rect participation of tRNA functional groups in the chemistry of
these non-proteogenic reactions has not yet been reported. One
might speculate that this reﬂects the fact that the aminoacylation
and peptidyl transferase reactions evolved contemporaneously in
the context of the RNA world, whereas the other reactions evolved
in a context where proteinaceous enzymes predominated. A criti-
cal problem that all non-proteogenic reactions that employ AA-
tRNAmust address is the diversion of aminoacylated intermediates
into protein synthesis. Current work argues that the selectivity by
elongation factors and the formation of complexes with enzymes
that follow in the reaction sequence provide at least two different
mechanisms to achieve sequestration away from ribosomes.
Whether additional tRNAs remain to be discovered that participate
only in non-proteogenic functions (like the Gly-tRNA from S. aur-
eus) is an interesting question that further whole genome sequenc-
ing projects should enlighten. A ﬁnal question concerns the
extension of the scaffolding principle to RNAs distinct from tRNA.
A recent chemical screen for biological small molecule-RNA conju-
gates indicates in E. coli and Streptomyces venezuelae led to the
detection of a number of such compounds, including 30-dephos-pho-CoA and other thioester derivatives of RNA [102]. The ﬁnding
of such compounds, and the depth of undiscovered biology they
imply, suggests that further functions of tRNA outside of protein
synthesis may yet be discovered.Acknowledgement
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